Company Profiles

driven by the PitchBook Platform

Regentis Biomaterials

Description

Operator of a tissue repair company. The company focuses on developing and commercializing an innovative hydrogel platform for the repair of damaged tissue.

2004

Founded

PRIVATE

Status

11-50

Employees

Series D

Latest Deal Type

$15M

Latest Deal Amount

$33.1M

Total Amount Raised

Description

Operator of a tissue repair company. The company focuses on developing and commercializing an innovative hydrogel platform for the repair of damaged tissue.

Website:

www.regentis.co.il

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Drug Discovery

Primary Office

2 Ha'ilan Street Northern Industrial Zone, P.O.Box 260 Or-Akiva 3060000Israel +972 (0)4 626 5502
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Regentis Biomaterials's full profile, request a free trial.

Regentis Biomaterials Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Regentis Biomaterials Investors (10)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Crossroad FCPVenture CapitalMinority000 0000000 0000
DSM VenturingCorporate Venture CapitalMinority000 0000000 0000
Generali Investments EuropeLimited PartnerMinority000 0000000 0000
Haisco Pharmaceutical GroupCorporationMinority000 0000000 0000
Medica Venture PartnersVenture CapitalMinority000 0000000 0000
Crossroad FCP Venture Capital
DSM Venturing Corporate Venture Capital
Generali Investments Europe Limited Partner
Haisco Pharmaceutical Group Corporation
Medica Venture Partners Venture Capital

Regentis Biomaterials Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Alastair Clemow Ph.DChief Executive Officer & President
Livnat Ben-ZurIsrael Office General Manager & Vice President, Business Development
Dror SeliktarCo-Founder & Chief Scientific Officer
Roni Wechsler Ph.DVice President, Research & Development
Alastair Clemow Ph.D Chief Executive Officer & President
Livnat Ben-Zur Israel Office General Manager & Vice President, Business Development
Dror Seliktar Co-Founder & Chief Scientific Officer
Roni Wechsler Ph.D Vice President, Research & Development

Regentis Biomaterials Board Members (6)

NameRepresentingRoleSinceContact
Info
Ehud Geller Ph.DMedica Venture PartnersFounder & Managing Partner000 0000
Eli Hazum Ph.DMedica Venture PartnersGeneral Partner & Chief Scientific Officer000 0000
Ian FreelanceDSM VenturingSenior Investment Manager000 0000
Jeff DykanSCP Vitalife PartnersManaging Partner000 0000
Keith ValentineSelfBoard Member000 0000
Ehud Geller Ph.D Founder & Managing Partner Medica Venture Partners
Eli Hazum Ph.D General Partner & Chief Scientific Officer Medica Venture Partners
Ian Freelance Senior Investment Manager DSM Venturing
Jeff Dykan Managing Partner SCP Vitalife Partners
Keith Valentine Board Member Self
Request full access to PitchBook